The China Medical City (CMC) science park in Taizhou is the location of an aspiring Regional Research Centre of the ICGEB. Over recent months delegations have visited Trieste and New Delhi.
On 25 February 2019, a delegation headed by Mr. Zhang Xiaobin, President of the CMC, Taizhou Medical Hi-tech Industrial Development Zone, met with Dr. Dinakar M. Salunke, ICGEB New Delhi Director, and Mr. Biju Mathew, ICGEB Administrative Officer, to discuss the structure, operations and scientific achievements of the Component.
The visit provided an opportunity to visit the extensive facilities at ICGEB New Delhi with a view to exploring common areas for cooperation with the Regional Research Centre being established in Taizhou.
The China RRC will focus on innovative research and development in vaccines, recombinant proteins, monoclonal antibodies, nucleic acids, viral vectors and other related fields of research, and will work together the the companies located in the China Medical Centre CMC for the development of biosimilar drugs. The CMC companies will receive technology transfer from the ICGEB China RRC.